glp 1 agonist saxenda Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of
Pay in 4 interest-free payments of $5.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/927460ae5e7258b165e8e96356418d0499b1aba4-8192x5464.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://unnatipharmax.com/wp-content/uploads/2025/09/Tashko-GLP1-1986-Discovery-169-1024x576-1.png)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://assets.nutrisense.io/62e18da95149ec2ee0d87b5b/64391413b3dfd719c09c4d23_1-types-of-glp-1-agonist-medications.webp)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://www.rivasweightloss.com/wp-content/uploads/2024/05/glp-1-banner.png)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://familycaremurphy.com/wp-content/uploads/2025/12/GLP-1-Weight-Loss-Medication-Guide-Choosing-Between-Wegovy-Ozempic-Saxenda.jpg)
![glp 1 agonist saxenda Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States FDA Approves Generic Version of](https://res.cloudinary.com/dzdh0jsge/image/upload/c_scale,f_auto,q_100,w_1024/tmn/static/product-saxenda.webp)



















